期刊
CLINICAL INFECTIOUS DISEASES
卷 50, 期 -, 页码 S156-S164出版社
OXFORD UNIV PRESS INC
DOI: 10.1086/651486
关键词
-
资金
- National Institute of Allergy and Infectious Diseases [30036, 079590, 37856, 36973]
- Center for Global Health Policy
- Infectious Diseases Society of America
- HIV Medicine Association, through the Bill & Melinda Gates Foundation
Recent epidemiological indicators of tuberculosis (TB) indicate that the Millennium Development Goal of TB elimination by 2050 will not be achieved. The majority of incident cases are occurring in population-dense regions of Africa and Asia where TB is endemic. The persistence of TB in the setting of poor existing health infrastructure has led to an increase in drug-resistant cases, exacerbated by the strong association with human immunodeficiency virus coinfection. Spreading drug resistance threatens to undo decades of progress in controlling the disease. Several significant gaps can be identified in various aspects of national-and international-directed TB-control efforts. Various governing bodies and international organizations need to address the immediate challenges. This article highlights some of the major policies that lawmakers and funding institutions should consider. Existing economic and social obstacles must be overcome if TB elimination is to be a reachable goal.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据